• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过具有PI3Kγ亚型选择性活性的惠斯根1,3-偶极环加成反应设计与合成1,4-取代的1H-1,2,3-三唑并喹唑啉-4(3H)-酮

Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kγ isoform selective activity.

作者信息

Srinivas M, Singh Pathania Anup, Mahajan Priya, Verma Praveen K, Chobe Santosh S, Malik Fayaz A, Nargotra Amit, Vishwakarma Ram A, Sawant Sanghapal D

机构信息

Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180 001, India; Academy of Scientific and Innovative Research, Anusandhan Bhawan, 2 Rafi Marg, New Delhi 110 001, India.

Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180 001, India; Academy of Scientific and Innovative Research, Anusandhan Bhawan, 2 Rafi Marg, New Delhi 110 001, India.

出版信息

Bioorg Med Chem Lett. 2018 Apr 1;28(6):1005-1010. doi: 10.1016/j.bmcl.2018.02.032. Epub 2018 Feb 16.

DOI:10.1016/j.bmcl.2018.02.032
PMID:29486969
Abstract

A strategy for construction of medicinally important 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones has been devised and presented here. The compounds have been synthesized using one-pot multicomponent strategy under microwave assisted conditions. Triazolyl-quinazolinone based D-ring modified analogs are designed based on IC87114 scaffold, which is first known isoform selective inhibitor of PI3Kδ. Herein, we identified two triazolyl-quinazolinone compounds (5a and 5l) based on same scaffold with PI3Kγ specific inhibitory potential, the selectivity towards this isoform is well supported by in silico results, wherein, these compounds show better interaction and affinity and inhibitory activity for PI3Kγ rather than PI3Kδ. This repositioning of scaffold from PI3Kδ to PI3Kγ isoform can be very useful from medicinal chemistry and drug discovery perspective to unravel molecular interactions of this new scaffold in different cellular pathways.

摘要

本文设计并展示了一种构建具有重要药用价值的1,4-取代-1H-1,2,3-三唑并喹唑啉-4(3H)-酮的策略。这些化合物是在微波辅助条件下采用一锅多组分策略合成的。基于IC87114支架设计了基于三唑基喹唑啉酮的D环修饰类似物,IC87114是首个已知的PI3Kδ亚型选择性抑制剂。在此,我们鉴定了两种基于相同支架且具有PI3Kγ特异性抑制潜力的三唑基喹唑啉酮化合物(5a和5l),计算机模拟结果充分支持了对该亚型的选择性,其中,这些化合物对PI3Kγ表现出比PI3Kδ更好的相互作用、亲和力和抑制活性。从药物化学和药物发现的角度来看,将支架从PI3Kδ重新定位到PI3Kγ亚型对于揭示这种新支架在不同细胞途径中的分子相互作用可能非常有用。

相似文献

1
Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kγ isoform selective activity.通过具有PI3Kγ亚型选择性活性的惠斯根1,3-偶极环加成反应设计与合成1,4-取代的1H-1,2,3-三唑并喹唑啉-4(3H)-酮
Bioorg Med Chem Lett. 2018 Apr 1;28(6):1005-1010. doi: 10.1016/j.bmcl.2018.02.032. Epub 2018 Feb 16.
2
Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors.发现新型喹唑啉酮衍生物作为高效且选择性的 PI3Kδ 和 PI3Kδ/γ 抑制剂。
Eur J Med Chem. 2018 May 10;151:9-17. doi: 10.1016/j.ejmech.2018.03.068. Epub 2018 Mar 23.
3
Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.一些 2,3-二取代喹唑啉-4(3H)-酮和 4,6-二取代-1,2,3,4-四氢喹唑啉-2H-酮的合成及抗肿瘤活性。
Eur J Med Chem. 2010 Dec;45(12):6058-67. doi: 10.1016/j.ejmech.2010.10.008. Epub 2010 Oct 15.
4
Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.新型 3-取代咪唑并[1,2-a]吡啶和喹唑啉-4(3H)-酮衍生物的设计、合成及作为 PI3Kα 抑制剂的生物评价。
Eur J Med Chem. 2017 Oct 20;139:95-106. doi: 10.1016/j.ejmech.2017.07.074. Epub 2017 Aug 1.
5
SAR study of 5-alkynyl substituted quinazolin-4(3H)-ones as phosphoinositide 3-kinase delta (PI3Kδ) inhibitors.5-炔基取代喹唑啉-4(3H)-酮作为磷酸肌醇3-激酶δ(PI3Kδ)抑制剂的构效关系研究
Eur J Med Chem. 2017 Jan 5;125:1156-1171. doi: 10.1016/j.ejmech.2016.11.014. Epub 2016 Nov 9.
6
Synthesis and Evaluation of Novel 2H-Benzo[e]-[1,2,4]thiadiazine 1,1-Dioxide Derivatives as PI3Kδ Inhibitors.新型 2H-苯并[e]-[1,2,4]噻二嗪 1,1-二氧化物衍生物的合成与评价作为 PI3Kδ 抑制剂。
Molecules. 2019 Nov 25;24(23):4299. doi: 10.3390/molecules24234299.
7
Quinazolin-4(3)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity.基于喹唑啉-4(3)-酮的具有优异细胞毒性的潜在多靶点酪氨酸激酶抑制剂。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):2055-2067. doi: 10.1080/14756366.2021.1972992.
8
Design, synthesis and biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment.设计、合成并评价喹唑啉酮衍生物作为 EGFR 抑制剂用于抗肿瘤治疗。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):555-564. doi: 10.1080/14756366.2020.1715389.
9
Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation.发现新型喹唑啉-4(3H)-酮类作为 VEGFR-2 抑制剂:设计、合成与抗增殖活性评价。
Bioorg Chem. 2020 Dec;105:104380. doi: 10.1016/j.bioorg.2020.104380. Epub 2020 Oct 15.
10
Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors.设计、合成及新型喹唑啉-4(3H)-酮类化合物的抗增殖活性评价作为潜在的 VEGFR-2 抑制剂。
Bioorg Med Chem. 2021 Jan 1;29:115872. doi: 10.1016/j.bmc.2020.115872. Epub 2020 Nov 12.

引用本文的文献

1
Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors.评估三唑取代的吡咯并嘧啶作为集落刺激因子1受体(CSF1R)抑制剂的作用
Molecules. 2025 Jun 18;30(12):2641. doi: 10.3390/molecules30122641.
2
Nanomagnetic macrocyclic Schiff-base-Mn(ii) complex: an efficient heterogeneous catalyst for click approach synthesis of novel β-substitued-1,2,3-triazoles.纳米磁性大环席夫碱-Mn(II)配合物:一种用于点击法合成新型β-取代-1,2,3-三唑的高效多相催化剂。
RSC Adv. 2022 Jun 16;12(28):17905-17918. doi: 10.1039/d2ra02587f. eCollection 2022 Jun 14.
3
1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.
含 1,2,3-三唑的杂合体作为药物化学中的先导化合物:最新概述。
Bioorg Med Chem. 2019 Aug 15;27(16):3511-3531. doi: 10.1016/j.bmc.2019.07.005. Epub 2019 Jul 4.